Titel	Veröffentlichungsdatum	Sprache	Zitate
From Translation to Version Management: A History and Review of Methods for the Cultural Adaptation of the EuroQol Five-Dimensional Questionnaire	2014/01/01	English	174
Clinical Outcome Assessments: Conceptual Foundation—Report of the ISPOR Clinical Outcomes Assessment – Emerging Good Practices for Outcomes Research Task Force	2015/09/01	English	169
Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan	2016/07/01	English	169
Measuring Change in Quality of Life: Bias in Prospective and Retrospective Evaluation	2015/01/01	English	164
Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making	2017/09/01	English	164
Review of Utility Values for Economic Modeling in Type 2 Diabetes	2014/06/01	English	161
Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores	2017/04/01	English	157
Economic Evaluation for Devices and Drugs—Same or Different?	2009/06/01	English	156
The EUROHIS-QOL 8-Item Index: Comparative Psychometric Properties to Its Parent WHOQOL-BREF	2012/05/01	English	156
Satisfaction with Medication: An Overview of Conceptual, Methodologic, and Regulatory Issues	2004/03/01	English	156
Validation of the IMS CORE Diabetes Model	2014/09/01	English	156
Adapting Quality of Life Instruments	2004/09/01	English	151
Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4	2012/09/01	English	147
Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy—Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer	2009/01/01	English	147
Quality of Life Assessed with the Medical Outcomes Study Short Form 36-Item Health Survey of Patients on Renal Replacement Therapy: A Systematic Review and Meta-Analysis	2007/09/01	English	147
Preference-Based Quality of Life of Patients on Renal Replacement Therapy: A Systematic Review and Meta-Analysis	2008/07/01	English	146
Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2	2012/09/01	English	145
An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard	2009/01/01	English	145
Persistence and Adherence of Medications for Chronic Overactive Bladder/Urinary Incontinence in the California Medicaid Program	2005/07/01	English	145
Comparing the EQ-5D and the SF-6D Descriptive Systems to Assess Their Ceiling Effects in the US General Population	2006/07/01	English	144
Development of EMPRO: A Tool for the Standardized Assessment of Patient-Reported Outcome Measures	2008/07/01	English	144
Labeled versus Unlabeled Discrete Choice Experiments in Health Economics: An Application to Colorectal Cancer Screening	2010/03/01	English	143
Adjusting for Inflation and Currency Changes Within Health Economic Studies	2019/09/01	English	141
Deriving an Algorithm to Convert the Eight Mean SF-36 Dimension Scores into a Mean EQ-5D Preference-Based Score from Published Studies (Where Patient Level Data Are Not Available)	2008/12/01	English	140
Medication Compliance Feedback and Monitoring in a Clinical Trial: Predictors and Outcomes	2003/09/01	English	140
Emerging Guidelines for Patient Engagement in Research	2017/03/01	English	136
Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report	2017/01/01	English	136
A Review of Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy—Report of the ISPOR Risk–Benefit Management Working Group	2010/07/01	English	136
Impact of Long-Term Complications on Quality of Life in Patients with Type 2 Diabetes not Using Insulin	2001/09/01	English	135
Impact of a University-Based Outpatient Telemedicine Program on Time Savings, Travel Costs, and Environmental Pollutants	2017/04/01	English	134